Abstract
Multiple sclerosis (MS) is a neurological, chronic, inflammatory, and progressive disease with musculoskeletal problems and neurodegenerative disorders that causes worsening of the health status of patients. The aim of this study was to determine the level of depression in MS patients compared to a population of healthy subjects. The established sample size was 116 subjects matched with the same age, sex, and body mass index. The subjects were recruited from different multiple sclerosis associations and neurology clinics in different public health areas (case group n = 58) and healthy subjects from the same locality (control group n = 58). The scores and categories of the Beck Depression Inventory (BDI) in its Spanish version were collected. There was a clear statistically significant difference (p < 0.05) in the BDI scores between both groups. As a result, we found that the subjects with MS presented worse results with BDI = 9.52 ± 7.70 points compared to the healthy subjects with a BDI score = 5.03 ± 5.14. Within the BDI categories, there were statistically significant differences (p < 0.001), which were greater for the MS group. Depression is a dangerous factor for MS patients, being a trigger for a poorer quality of life.
Subject
Health Information Management,Health Informatics,Health Policy,Leadership and Management
Reference44 articles.
1. The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years;Baranzini;Trends Genet.,2017
2. The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis;Mallucci;Prog. Neurobiol.,2015
3. Epidemiology of multiple sclerosis in Portugal and Spain;De Sá;Rev. Neurol.,2010
4. Soares, M. de la Qualidade de vida e Esclerose Múltipla, 2002.
5. Multiple sclerosis and depression;Feinstein;Mult. Scler. J.,2011
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献